Dr. Rupert E. Exconde, MD

Dr. Exconde practices at Noran Neurological Clinic P.A. in Minneapolis, Minnesota.

Dr. Exconde's NPI, 1780613075, was assigned on July 1, 2006. Dr. Exconde graduated from University of Santo Tomas in 1993. Dr. Exconde holds Minnesota license 40392.

Dr. Exconde's primary practice is Noran Neurological Clinic P.A., at 3601 Minnesota Dr, Minneapolis, MN 55435 in Hennepin County. The practice phone is (612) 879-1000.

Dr. Exconde's primary practice is Noran Neurological Clinic P.A. in Minneapolis, Minnesota. Dr. Exconde is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Exconde to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Exconde practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Exconde's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Exconde is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Exconde is licensed in Minnesota.

Dmand AI lists epilepsy, hereditary polyneuropathy, migraine and chronic headache, mobility impairment and neuropathy among the conditions Dr. Exconde treats.

CMS data shows 112 Medicare services from Dr. Exconde across 4 procedure codes in 2024, for 85 Medicare patients. Medicare paid $6,419 for them.

CMS counts 85 Medicare patients who saw Dr. Exconde in 2024. The largest group is under 65, with 48 patients. 47% of them have high blood pressure, and 44% have mood disorders. 66% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Exconde's median patient age at 49, with 52% women.

In 2024, Dr. Exconde wrote 1,353 Medicare Part D claims for 62 patients. 84% of them were for generic drugs. CMS names the drug for 1,298 of them, across 36 drugs with 11 or more claims each, at $409,875 in total drug cost. In 2023, CMS named 1,873 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Exconde for performance year 2024, reported as part of a group. Dr. Exconde accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Exconde.

CMS Open Payments shows 109 general payments to Dr. Exconde from 7 drug and device companies from 2016 to 2021. Speaker and faculty fees make up the largest share, 64% of the total. UCB, Inc. paid the most, $35,090.

Dmand AI lists 1 award for Dr. Exconde, most recently CMS Stage 1 2012 in 2012.

Dr. Exconde graduated from University of Santo Tomas in 1993. Dr. Exconde is a member of AAN, AES and Epilepsy Foundation of MN.

Dr. Exconde is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Medica. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.